{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:46:39Z","timestamp":1789681599837,"version":"4.0.1"},"reference-count":11,"publisher":"The Editorial Committee of Annals of Vascular Diseases","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Vascular Diseases","Ann Vasc Dis","AVD"],"published-print":{"date-parts":[[2022,12,25]]},"DOI":"10.3400\/avd.oa.22-00099","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T22:25:35Z","timestamp":1665527135000},"page":"268-274","source":"Crossref","is-referenced-by-count":1,"title":["Useful Test for Classification of Cerebral Infarction at Hospital Specializing in Neurosurgery"],"prefix":"10.3400","volume":"15","author":[{"given":"Hirotaka","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tokyo General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Nishitani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kitahara International Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1983","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ueno Y, Urabe T, Hattori N, et al. Relationship between prognosis of embolic stroke of undetermined source and underlying embolic etiologies on transesophageal echocardiography. Japanese Journal of Stroke 2017; <b>40<\/b>: 100-4. (in Japanese)","DOI":"10.3995\/jstroke.10508"},{"key":"2","unstructured":"2) Shimamura M, Hashimoto Y, Orita S, et al. Diagnosis of intracardiac right-to-left shunt by transcranial color-flow imaging: comparison between patients with cardiovascular disease, ischemic stroke, and ocular ischemic syndrome. Neurosonology 2001; <b>14<\/b>: 15-9. (in Japanese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bilchick KC, Mealor A, Gonzalez J, et al. Effectiveness of integrating delayed computed tomography angiography imaging for left atrial appendage thrombus exclusion into the care of patients undergoing ablation of atrial fibrillation. Heart Rhythm 2016; <b>13<\/b>: 12-9.","DOI":"10.1016\/j.hrthm.2015.09.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nogawa S. Cancer-associated stroke\u2014clinical management of Trousseau\u2019s syndrome. Nihon Kessen Shiketsu Gakkai shi 2016; <b>27<\/b>: 18-28. (in Japanese)","DOI":"10.2491\/jjsth.27.18"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shibazaki K, Kimura K, Iguchi Y, et al. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 2009; <b>48<\/b>: 259-64.","DOI":"10.2169\/internalmedicine.48.1475"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shibazaki K, Kimura K, Fujii S, et al. Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke. Am J Cardiol 2012; <b>109<\/b>: 1303-7.","DOI":"10.1016\/j.amjcard.2011.12.022"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hariri E, Hachem A, Sarkis G, et al. Optimal duration of monitoring for atrial fibrillation in cryptogenic stroke: a nonsystematic review. BioMed Res Int 2016; <b>2016<\/b>: 5704963. doi: 10.1155\/2016\/5704963","DOI":"10.1155\/2016\/5704963"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Higgins P, MacFarlane PW, Dawson J, et al. Noninvasive cardiac event monitoring to detect atrial fibrillation after ischemic stroke. Stroke 2013; <b>44<\/b>: 2525-31.","DOI":"10.1161\/STROKEAHA.113.001927"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sanna T, Diener HC, Passman RS, et al.; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; <b>370<\/b>: 2478-86.","DOI":"10.1056\/NEJMoa1313600"},{"key":"10","unstructured":"10) Hart RG, Sharma M, Mundl H, et al.; NAVIGATE ESUS Investigators. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 2018; <b>378<\/b>: 2191-201."},{"key":"11","unstructured":"11) Diener HC, Sacco RL, Easton JD, et al.; RE-SPECT ESUS Steering Committee and Investigators. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 2019; <b>380<\/b>: 1906-17."}],"container-title":["Annals of Vascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/15\/4\/15_oa.22-00099\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T04:23:57Z","timestamp":1672460637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/avd\/15\/4\/15_oa.22-00099\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,25]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3400\/avd.oa.22-00099","relation":{},"ISSN":["1881-641X","1881-6428"],"issn-type":[{"value":"1881-641X","type":"print"},{"value":"1881-6428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,25]]},"article-number":"oa.22-00099"}}